KALA · KALA BIO, Inc.
$0.71
+0.04 (+5.38%)
At close · Jul 30
Market Cap
$12.52M
Shares
18.59M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-03-17 | New | Pharmaceuticals | $1,753,500 | $1,753,500 | 06b |
| 2026-02-13 | New | Biotechnology | $4,200,000 | $2,250,600 | 06b |
| 2024-12-31 | New | Biotechnology | $10,749,667 | $10,749,667 | 06b |
| 2024-06-28 | New | Biotechnology | $12,499,192 | $12,499,192 | 06b |
| 2021-11-29 | New | Biotechnology | $36,522,541 | $16,122,541 | 06b |
Showing 1–5 of 5 filings